AUTOLUS THERAPEUTICS PLC - AMERICAN DEPOSITARY SHA

Autolus Therapeutics to hold Analyst call to highlight data at ASCO from the Pivotal Phase 2 FELIX study of obe-cel data in adult r/r B-ALL

22 مايو 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics announces Pivotal Phase 2 FELIX study of obe-cel in adult r/r B-ALL selected for an oral presentation at EHA

12 مايو 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Reports First Quarter 2023 Financial Results and Operational Progress

04 مايو 2023 06:00:02 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics announces Pivotal Phase 2 FELIX study of obe-cel in adult r/r B-ALL selected for an oral presentation at ASCO

27 أبريل 2023 06:01:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Selects Cardinal Health as U.S. Commercial Distribution Partner

27 أبريل 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Announces Publication in Molecular Therapy Nucleic Acids

26 أبريل 2023 15:01:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Announces Data from AUTO1/22 Trial in Pediatric Acute Lymphoblastic Leukemia in an Oral Presentation at the EBMT 49th Annual Meeting

26 أبريل 2023 06:06:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics to Host Virtual Capital Markets Day

25 أبريل 2023 06:00:01 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics to Report First Quarter 2023 Financial Results and Host Conference Call on May 4, 2023

20 أبريل 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Announces Publication in Molecular Therapy

04 أبريل 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics announces resignation of Chief Financial Officer

14 مارس 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Has No Business Relationship with Silicon Valley Bank

13 مارس 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Reports Full Year 2022 Financial Results and Operational Progress

07 مارس 2023 06:00:01 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on March 7, 2023

15 فبراير 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics announces Board changes

20 يناير 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease

09 يناير 2023 06:00:02 بحسب Nasdaq GlobeNewswire

Autolus Announces Partial Exercise of Underwriters' Option to Purchase Additional ADSs

21 ديسمبر 2022 15:01:00 بحسب Nasdaq GlobeNewswire

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022

12 ديسمبر 2022 09:00:00 بحسب Nasdaq GlobeNewswire

Autolus Announces Pricing of Public Offering

08 ديسمبر 2022 20:11:25 بحسب Nasdaq GlobeNewswire

Autolus Announces Proposed Public Offering in the United States

08 ديسمبر 2022 15:03:13 بحسب Nasdaq GlobeNewswire